According to the latest report by IMARC Group “Peptide Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global peptide therapeutics market reached a value of US$ 35.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 61.9 Billion by 2027, exhibiting a CAGR of 9.42% during 2022-2027.
Peptides are selective signaling molecules that bind to specific cell surface receptors, such as G protein-coupled receptors (GPCRs) or ion channels, and trigger intracellular effects. They are extensively utilized in the pharmaceutical industry to design regenerative therapeutics that target a wide range of cells and influence their responses. Peptide therapeutics are less toxic, well-tolerated, and relatively safer than other treatment options. As a result, they are gaining traction in clinical practices for managing cancer, infectious diseases, metabolic disorders, injuries, etc.
Request for a free sample copy of this report: https://www.imarcgroup.com/peptide-therapeutics-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Market Trends:
The escalating prevalence of chronic diseases and improving access to medical facilities are positively influencing the peptides market. Furthermore, peptide therapies are also utilized in cosmeceutical surgeries to slow down the process of skin aging, which is catering to the growing consumer consciousness towards physical appearance. Apart from this, with the emergence of novel synthetic strategies that minimize injection frequency and improve stability, peptide therapeutics are being extensively used in injections for diabetic patients. Moreover, the rising trend of personalized and targeted treatments is further bolstering the demand for multifunctional peptide-based materials. This, along with the increasing funding to develop new peptide therapeutics for treating inflammatory autoimmune diseases, is expected to fuel the market growth in the coming years.
Breakup by Type:
- Innovative
- Generic
Breakup by Type of Manufacturer:
- Outsourced
- In-house
Breakup by Synthesis Technology:
- Solid Phase Peptide Synthesis
- Liquid Phase Peptide Synthesis
- Hybrid Technology
Breakup by Routes of Administration:
- Parenteral
- Oral
- Others
Breakup by Application:
- Gastrointestinal Disorders
- Neurological Disorders
- Metabolic Disorders
- Cancer
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Amgen Inc.
- Apitope International NV
- Arch Biopartners Inc.
- AstraZeneca plc
- Circle Pharma Inc.
- Corden Pharma GmbH
- F. Hoffmann-La Roche AG
- Ipsen Group
- Lonza Group AG
- Novo Nordisk A/S
- Pfizer Inc.
- Teva Pharmaceuticals Industries Ltd.
- Zealand Pharma A/S.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/peptide-therapeutics-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
